UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy

British journal of haematology, 2019-08, Vol.186 (3), p.e31-e35

2019

Volltextzugriff (PDF)

Paediatric rhabdomyolysis: A UK centre's 10‐year retrospective experience

Journal of paediatrics and child health, 2023-02, Vol.59 (2), p.346-351

2023

Volltextzugriff (PDF)

Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles

Current oncology (Toronto), 2023-11, Vol.30 (12), p.10211-10223

2023

Volltextzugriff (PDF)

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

Clinical cancer research, 2016-07, Vol.22 (13), p.3249-3259

2016

Volltextzugriff (PDF)

Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice

Journal of oncology pharmacy practice, 2020-06, Vol.26 (4), p.912-917

2020

Volltextzugriff (PDF)

Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions

Clinical journal of oncology nursing, 2018-02, Vol.22 (1), p.76-82

2018

Volltextzugriff (PDF)

Developing an applied informatics course for a doctor of nursing practice program

Nurse educator, 2013-01, Vol.38 (1), p.37-42

2013

Volltextzugriff (PDF)

Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer

BMC cancer, 2019-11, Vol.19 (1), p.1036-1036, Article 1036

2019

Volltextzugriff (PDF)

Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4693-4700

2009

Volltextzugriff (PDF)

Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer

Human pathology, 2012-06, Vol.43 (6), p.865-873

2012

Volltextzugriff (PDF)

Normalizing the use of patient-provider agreement for opioid treatment within a cancer institute

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.251-251

2019

Volltextzugriff (PDF)

Feasibility trial of child care as a therapeutic intervention

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24196-e24196

2023

Volltextzugriff (PDF)

Abstract PS7-57: Patient risk factors for loss to breast oncologic follow up

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS7-57-PS7-57

2021

Volltextzugriff (PDF)

Implementing clinic to home telehealth services to promote quality of life for ambulatory oncology palliative care patients

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.259-259

2020

Volltextzugriff (PDF)

Breathing space – graduate entrepreneurs’ perspectives of entrepreneurship education in higher education

Education & training (London), 2014-11, Vol.56 (8/9), p.733-744

2014

Volltextzugriff (PDF)

A Randomized Trial Testing An Automated Internet Program For Increasing Physical Activity Among Cancer Survivors: 1207

Medicine and science in sports and exercise, 2024-10, Vol.56 (10S), p.383-384

2024

Volltextzugriff (PDF)

Exploring Improvisation in Nursing

Journal of holistic nursing, 2007-06, Vol.25 (2), p.126-133

2007

Volltextzugriff (PDF)

Patient navigation for breast cancer patients with disabilities

Journal of clinical oncology, 2013-09, Vol.31 (26_suppl), p.130-130

Fenton, Mary Anne

2013

Volltextzugriff (PDF)

Responding to the opioid crisis in a manner that respects oncology patients: A single institution experience writing policy to promote safe opioid use

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.132-132

2018

Volltextzugriff (PDF)

Quality improvement outcomes in an academic practice participating in ASCO’s Quality Oncology Practice Initiative (QOPI)

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.206-206

Fenton, Mary Anne

2012

Volltextzugriff (PDF)

Patient experience with breast cancer care delivered in a multidisciplinary clinic

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13506-e13506

2022

Volltextzugriff (PDF)

Admission to the ICU in the last 30 days of life and systemic anticancer therapy in the last two weeks of life at Lifespan Cancer Institute (LCI)

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.214-214

2020

Volltextzugriff (PDF)

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to Preoperative Trastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

Clinical cancer research, 2016-07, Vol.22 (13), p.3249-3259

2016

Volltextzugriff (PDF)

Fulfilling the Role of a Parent While Undergoing Treatment for Cancer: A Review of the Literature and the Potential Impact of Childcare Support on Cancer Outcomes

American journal of clinical oncology, 2024-09, Vol.47 (9), p.445-447

2024

Volltextzugriff (PDF)

Retrospective chart review to characterize admission to the ICU in the last 30 days of life and use of systemic anticancer therapy in the last two weeks of life at the Lifespan Cancer Institute

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19202-e19202

2020

Volltextzugriff (PDF)

1 – 25 von 415

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(327)
Mit Volltextzugriff
(295)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(415)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy

Paediatric rhabdomyolysis: A UK centre's 10‐year retrospective experience

Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice

Prechemotherapy Education: Reducing Patient Anxiety Through Nurse-Led Teaching Sessions

Developing an applied informatics course for a doctor of nursing practice program

Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer

Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study

Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer

Normalizing the use of patient-provider agreement for opioid treatment within a cancer institute

Feasibility trial of child care as a therapeutic intervention

Abstract PS7-57: Patient risk factors for loss to breast oncologic follow up

Implementing clinic to home telehealth services to promote quality of life for ambulatory oncology palliative care patients

Breathing space – graduate entrepreneurs’ perspectives of entrepreneurship education in higher education

A Randomized Trial Testing An Automated Internet Program For Increasing Physical Activity Among Cancer Survivors: 1207

Exploring Improvisation in Nursing

Patient navigation for breast cancer patients with disabilities

Responding to the opioid crisis in a manner that respects oncology patients: A single institution experience writing policy to promote safe opioid use

Quality improvement outcomes in an academic practice participating in ASCO’s Quality Oncology Practice Initiative (QOPI)

Patient experience with breast cancer care delivered in a multidisciplinary clinic

Admission to the ICU in the last 30 days of life and systemic anticancer therapy in the last two weeks of life at Lifespan Cancer Institute (LCI)

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to Preoperative Trastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

Fulfilling the Role of a Parent While Undergoing Treatment for Cancer: A Review of the Literature and the Potential Impact of Childcare Support on Cancer Outcomes

Retrospective chart review to characterize admission to the ICU in the last 30 days of life and use of systemic anticancer therapy in the last two weeks of life at the Lifespan Cancer Institute

Suchergebnisse filtern